Chart 4. Evaluation of pulmonary rehabilitation effectiveness.
| Essential and conditional examinations/investigations | Adaptation to special settings and situations |
|---|---|
| Lung function | |
| • Spirometry (FEV1, FVC, FEV1/FVC) • Plethysmography |
• Spirometry (FEV1, FVC, FEV1/FVC) |
| Gas transfer | |
| • Pao2
• Paco2 • Pulse oximetry (SpO2, % desaturation) • DLco, Kco |
• Pulse oximetry (SpO2, % desaturation) |
| Exercise capacity | |
| • 6MWT • Vo2max • ISWT • 5STS |
• 6MWT • 5STS |
| Health-related quality of life | |
| • EUROHIS-QoL 8 • SGRQ • WHOQOL-BREF • Pediatric: EQ-5D-Y and TANDI |
• EUROHIS-QoL 8 • SGRQ • WHOQOL-BREF • Pediatric: EQ-5D-Y and TANDI |
| Self-reported symptoms | |
| • mMRC • VAS • modified Borg scale |
• mMRC • VAS • modified Borg scale |
| Acute infectious exacerbations (e.g., in bronchiectasis) requiring antibiotic and/or steroid treatment | |
| Number of episodes | Number of episodes |
| Hospitalization | |
| Number of episodes/hospital days | Number of episodes/hospital days |
| Mortality | |
| Number of deaths | Number of deaths |
Kco: carbon monoxide transfer coefficient; 6MWT: six-minute walk test; ISWT: incremental shuttle walk test; 5STS: 5 repetitions sit-to-stand test; EUROHIS-QoL: European Health Interview Survey-Quality of Life; SGRQ: St. George’s Respiratory Questionnaire; WHOQOL-BREF: World Health Organization Quality of Life Instrument, brief version; TANDI: Toddler and Infant (instrument); mMRC: modified Medical Research Council; and VAS: visual analogue scale.